Clinical pharmacokinetics of oxaliplatin: a critical review.

奥沙利铂 药代动力学 医学 肾功能 铂金 肾脏生理学 排泄 白蛋白 间隙 血液蛋白质类 结直肠癌 内科学 药理学 泌尿科 内分泌学 癌症 化学 生物化学 催化作用
作者
Martin A. Graham,G. Lockwood,Dennis Greenslade,S. Brienza,M. Bayssas,Érick Gamelin
出处
期刊:PubMed 卷期号:6 (4): 1205-18 被引量:447
链接
标识
摘要

Oxaliplatin (cis-[(1R,2R)-1,2-cyclohexanediamine-N,N'] oxalato(2-)-O,O'] platinum; Eloxatine) is a novel platinum coordination complex used for the treatment of metastatic colorectal carcinoma in combination with fluoropyrimidines. The objective of this review is to integrate the key data from multiple studies into a single, comprehensive overview of oxaliplatin disposition in cancer patients. The pharmacokinetics (PKs) of unbound platinum in plasma ultrafiltrate after oxaliplatin administration was triphasic, characterized by a short initial distribution phase and a long terminal elimination phase (t1/2, 252-273 h). No accumulation was observed in plasma ultrafiltrate after 130 mg/m2 every 3 weeks or 85 mg/m2 every 2 weeks. Interpatient and intrapatient variability in platinum exposure (area under the curve(0-48)) is moderate to low (33 and 5% respectively). In the blood, platinum binds irreversibly to plasma proteins (predominantly serum albumin) and erythrocytes. Accumulation of platinum in blood cells is not considered to be clinically significant. Platinum is rapidly cleared from plasma by covalent binding to tissues and renal elimination. Urinary excretion (53.8 +/- 9.1%) was the predominant route of platinum elimination, with fecal excretion accounting for only 2.1 +/- 1.9% of the administered dose 5 days postadministration. Tissue binding and renal elimination contribute equally to the clearance of ultrafilterable platinum from plasma. Renal clearance of platinum significantly correlated with glomerular filtration rate, indicating that glomerular filtration is the principal mechanism of platinum elimination by the kidneys. Clearance of ultrafilterable platinum is lower in patients with moderate renal impairment; however, no marked increase in drug toxicity was reported. The effect of severe renal impairment on platinum clearance and toxicity is currently unknown. Covariates such as age, sex, and hepatic impairment had no significant effect on the clearance of ultrafilterable platinum, and dose adjustment due to these variables is not required. Oxaliplatin undergoes rapid and extensive nonenzymatic biotransformation and is not subjected to CYP450-mediated metabolism. Up to 17 platinum-containing products have been observed in plasma ultrafiltrate samples from patients. These include several proximate cytotoxic species, including the monochloro-, dichloro-, and diaquo-diaminocyclohexane platinum complexes, along with several other noncytotoxic products. Oxaliplatin does not inhibit CYP450 isoenzymes in vitro. Platinum was not displaced from plasma proteins by a variety of concomitant medications tested in vitro, and no marked PK interactions between oxaliplatin, 5-fluorouracil, and irinothecan have been observed. These results indicate that the additive/synergistic antitumor activity observed with these agents is not due to major alterations in drug exposure, and the enhanced efficacy is likely to be mechanistically based. Together, these PK, biotransformation, drug-drug interaction analyses and studies in special patient populations provide a firm scientific basis for the safe and effective use of oxaliplatin in the clinic. These analyses also reveal that the pharmacological activity of oxaliplatin may be attributable, at least in part, to the unique pattern of platinum disposition observed in patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
2秒前
善学以致用应助薛华倩采纳,获得10
4秒前
huqingtao完成签到,获得积分10
4秒前
了了完成签到,获得积分10
4秒前
5秒前
5秒前
666完成签到,获得积分10
6秒前
9秒前
10秒前
星辰大海应助樱桃窝窝头采纳,获得10
11秒前
258369完成签到,获得积分10
12秒前
13秒前
14秒前
Sunwenrui发布了新的文献求助10
15秒前
薛华倩发布了新的文献求助10
19秒前
白白SAMA123发布了新的文献求助10
19秒前
19秒前
昏睡的飞机完成签到,获得积分10
19秒前
20秒前
21秒前
23秒前
miaojuly发布了新的文献求助10
23秒前
共享精神应助追寻筮采纳,获得10
23秒前
24秒前
莫歌完成签到 ,获得积分10
24秒前
2889580752发布了新的文献求助10
25秒前
量子星尘发布了新的文献求助10
25秒前
杨冠文发布了新的文献求助10
25秒前
HOME发布了新的文献求助10
27秒前
liz_应助努力工作的人采纳,获得10
28秒前
Lycerdoctor发布了新的文献求助10
28秒前
东瓜魔法师完成签到,获得积分10
28秒前
杨冠文完成签到,获得积分10
30秒前
30秒前
Owen应助肖肖采纳,获得10
31秒前
han应助薛华倩采纳,获得10
32秒前
Rational完成签到,获得积分10
32秒前
祁i应助liuzengzhang666采纳,获得10
33秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988868
求助须知:如何正确求助?哪些是违规求助? 3531255
关于积分的说明 11253071
捐赠科研通 3269858
什么是DOI,文献DOI怎么找? 1804822
邀请新用户注册赠送积分活动 881994
科研通“疑难数据库(出版商)”最低求助积分说明 809035